Thomas L. Schwartz, MD | Psychiatrist.com

Educational Activity

Mechanism of Action in Antidepressants

May 25, 2016

How do you handle patients who do not respond adequately to SSRI treatment? Explore this new Case and Comment to compare Maria's response to different antidepressant medications and learn...

Thomas L. Schwartz

Educational Activity

Using Mechanism of Action to Choose Medications for Treatment-Resistant Depression

September 23, 2015

Michael E. Thase, Thomas L. Schwartz

Academic Highlights

Choosing Medications for Treatment-Resistant Depression

June 24, 2015

What can you do for your patients with depression who show partial response or no response to treatment? Follow a discussion by expert faculty about how altering levels of...

Michael E. Thase, Thomas L. Schwartz

Original Research

Open-Label Treatment With Citalopram in Patients With Irritable Bowel Syndrome: A Pilot Study

August 15, 2005

Prakash S. Masand, Sanjay Gupta, Thomas L. Schwartz, et al

Original Research

An Open-Label Study of Adjunctive Modafinil in Patients With Sedation Related to Serotonergic Antidepressant Therapy

September 1, 2004

Thomas L. Schwartz, Nouman Azhar, Kim Cole, et al

Original Research

Comparison of Risperidone and Olanzapine in Bipolar and Schizoaffective Disorders

April 1, 2002

Prakash S. Masand, Xiaohong Wang, Sanjay Gupta, et al

Original Research

Paroxetine in Patients With Irritable Bowel Syndrome: A Pilot Open-Label Study

February 1, 2002

Prakash S. Masand, Sanjay Gupta, Thomas L. Schwartz, et al

Original Research

Divalproex Sodium Versus Valproic Acid in Hospital Treatment of Psychotic Disorders

April 1, 2000

Thomas L. Schwartz, Jose L. Massa, Sanjay Gupta, et al

Original Research

Treatment of Delirium With Quetiapine

February 1, 2000

Thomas L. Schwartz, Prakash S. Masand